Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review

• Main Authors: Thahesh Tharmaraja (Author), Jamie S.Y. Ho (Author), Ching-Hui Sia (Author), Nicole-Ann Lim (Author), Yao Feng Chong (Author), Amanda Y.L. Lim (Author), Rahul R. Rathakrishnan (Author), Leonard L.L. Yeo (Author), Vijay K. Sharma (Author), Benjamin Y.Q. Tan (Author)
• Format: Book
• Published: SAGE Publishing, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a group of antidiabetic medications with a favourable cardiovascular, renal and overall safety profile. Given the limited treatment options available for neurological disorders, it is important to determine whether the pleiotropic ef...